The global cough medicine market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The major factor for the growth of the market during the forecast period is the rising geriatric population as they are more prone to cough and cold. According to the United Nations, the US population in 2018 was 46.7 million, with roughly 17.5 percent of the population aged 65 and up. Although the population is predicted to remain steady, the geriatric population share is expected to increase to 19.7% by 2025.
Browse the full report description “Global Cough Medicine Market Size, Share & Trends Analysis Report by Product Type (Expectorants, Antihistamines, Decongestants & Antibiotics), by Age Group (Pediatric, Adult) and by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, & Online pharmacy) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/cough-medicine-market
In addition, the increasing pollution coupled with the rising development of research and development activities is further contributing to the growth of the market. As per the American Lung Association report 2020, more than 135 million people live with polluted air, putting their life and health at risk. Air pollution is one of the key environmental issues in the US. As per the World Economic Forum, poor air quality costs the US up to $617 billion every year. In addition, according to the estimation of EPA, the US spends about $65 billion every year to clean the air. According to the Air Quality Index 2020, Yosemite Lakes, in California, is the most polluted city in the US and the US ranked 84 globally in air pollution in 2020. The cough syrup is widely used in the treatment of dry cough due to prolonged exposure to low levels of air, tobacco, household smoke, and air pollution
In addition, the development of various products, such as cough syrups with minimal side effects, act as other growth factors. The manufacturers of the product make a variety of fortified natural remedies and ingredients that have the effect of strengthening the immune system. For instance, in September 2021, Sun Pharmaceutical Industries Ltd. announced the launch of Chericof 12 (Dextromethorphan Hydrobromide and Chlorpheniramine Maleate in India.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- including AstraZeneca plc, GlaxoSmithKline plc, Novartis International AG, and others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Cough Medicine Market Report Segment
By Product Type
By Age Group
By Distribution Channel
Global Cough Medicine Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World